These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22149967)

  • 1. The use of antipsychotics in a medium-long stay psychiatric hospital from 1998 to 2010.
    Lertxundi U; Echaburu SD; Palacios RH
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):143-7. PubMed ID: 22149967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Consumption and cost of antipsychotic drugs].
    Pérez J; Marín N; Vallano A; Castells X; Capellà D
    Actas Esp Psiquiatr; 2005; 33(2):110-6. PubMed ID: 15768318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey.
    Kennedy J; Tien YY; Cohen LJ; Sclar DA; Liu D; Blodgett EG; Engle J
    Clin Ther; 2009 Dec; 31(12):2931-9. PubMed ID: 20110033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
    Jing Y; Johnston SS; Fowler R; Bates JA; Forbes RA; Hebden T
    J Med Econ; 2011; 14(6):777-86. PubMed ID: 21954966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of clinical use of antipsychotics in hospitalized psychiatric patients.
    Mauri MC; Regispani F; Beraldo S; Volonteri LS; Ferrari VM; Fiorentini A; Invernizzi G
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):957-63. PubMed ID: 16051409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06.
    O'Reilly DJ; Goeree RA; Tarride JE; James C; Parfrey PS
    Can J Clin Pharmacol; 2009; 16(2):e346-59. PubMed ID: 19531813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
    Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
    Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual health outcomes and treatment costs for schizophrenia populations.
    Mauskopf JA; David K; Grainger DL; Gibson PJ
    J Clin Psychiatry; 1999; 60 Suppl 19():14-9; discussion 20-2. PubMed ID: 10507276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors related to prescription dosage in Japanese psychiatric hospitals.
    Nawata S; Yamauchi K; Ikegami N
    Psychiatry Clin Neurosci; 2005 Feb; 59(1):70-6. PubMed ID: 15679543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004.
    Centorrino F; Ventriglio A; Vincenti A; Talamo A; Baldessarini RJ
    Hum Psychopharmacol; 2010 Mar; 25(2):179-86. PubMed ID: 20196186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inpatient antipsychotic drug use in 1998, 1993, and 1989.
    Centorrino F; Eakin M; Bahk WM; Kelleher JP; Goren J; Salvatore P; Egli S; Baldessarini RJ
    Am J Psychiatry; 2002 Nov; 159(11):1932-5. PubMed ID: 12411232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic polypharmacy at the University Psychiatric Hospital in Serbia.
    Divac N; Jasović-Gasić M; Samardzić R; Lacković M; Prostran M
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1250-1. PubMed ID: 17960865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic drug use: McLean Hospital, 2002.
    Centorrino F; Fogarty KV; Sani G; Salvatore P; Cimbolli P; Baldessarini RJ
    Hum Psychopharmacol; 2005 Jul; 20(5):355-8. PubMed ID: 15957153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of combinations of antipsychotics: McLean Hospital inpatients, 2002.
    Centorrino F; Fogarty KV; Sani G; Salvatore P; Cincotta SL; Hennen J; Guzzetta F; Talamo A; Saadeh MG; Baldessarini RJ
    Hum Psychopharmacol; 2005 Oct; 20(7):485-92. PubMed ID: 16116665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotics and antidepressants: an analysis of cost growth in Finland from 1999 to 2005.
    Koskinen H; Martikainen JE; Maljanen T
    Clin Ther; 2009 Jun; 31 Pt 1():1469-77. PubMed ID: 19698904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.